Mahdyoon H, Battilana G, Rosman H, Goldstein S, Gheorghiade M
Henry Ford Heart and Vascular Institute, Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, MI 48202.
Am Heart J. 1990 Nov;120(5):1189-94. doi: 10.1016/0002-8703(90)90135-k.
Digoxin intoxication has been reported to be a common adverse drug reaction with an in-hospital incidence of 6% to 23% and an associated mortality rate as high as 41%. A retrospective review was conducted to assess the accuracy of diagnosis, the morbidity and mortality of digoxin intoxication, and its incidence in hospitalized patients with heart failure. We reviewed the medical records of 219 patients discharged with the diagnosis of digoxin intoxication between 1980 and 1988. Patients were classified as follows: (1) Definite intoxication--patients with symptoms and/or arrhythmias suggestive of digoxin intoxication that resolved after discontinuation of digoxin; (2) possible intoxication--patients with symptoms and/or arrhythmias suggestive of digoxin intoxication in the absence of documented resolution after discontinuation of digoxin, or the presence of other clinical illnesses that could possibly account for those findings; (3) no intoxication--patients whose symptoms or ECG abnormalities were clearly explained by other associated clinical illnesses and persisted after withdrawal of digoxin. We identified only 43 patients (20%) with definite intoxication. The majority of patients discharged with the diagnosis of digoxin intoxication (133 or 60%) were classified as possibly digoxin intoxicated, and 43 patients (20%) had no clinical evidence to support this diagnosis. To estimate the incidence of digoxin intoxication, we also reviewed the medical records of 994 patients admitted in 1987 with heart failure. Of these, 563 were receiving digoxin and in 27 the diagnosis of digoxin intoxication was made by their clinicians. Our review showed that only four were definitely intoxicated (0.8%), and the diagnosis could not be excluded in another 16 (4%).(ABSTRACT TRUNCATED AT 250 WORDS)
据报道,地高辛中毒是一种常见的药物不良反应,院内发生率为6%至23%,相关死亡率高达41%。进行了一项回顾性研究,以评估地高辛中毒的诊断准确性、发病率和死亡率及其在住院心力衰竭患者中的发生率。我们回顾了1980年至1988年间出院诊断为地高辛中毒的219例患者的病历。患者分类如下:(1)确诊中毒——有提示地高辛中毒的症状和/或心律失常,停用后症状缓解的患者;(2)可能中毒——有提示地高辛中毒的症状和/或心律失常,但停用后无记录显示症状缓解,或存在其他可能解释这些发现的临床疾病的患者;(3)无中毒——症状或心电图异常可由其他相关临床疾病明确解释,且停用后仍持续存在的患者。我们仅确定了43例(20%)确诊中毒患者。大多数出院诊断为地高辛中毒的患者(133例,占60%)被分类为可能地高辛中毒,43例(20%)患者没有临床证据支持这一诊断。为了估计地高辛中毒的发生率,我们还回顾了1987年入院的994例心力衰竭患者的病历。其中,563例正在接受地高辛治疗,其临床医生对27例做出了地高辛中毒的诊断。我们的研究表明,只有4例确诊中毒(0.8%),另有16例(4%)不能排除中毒诊断。(摘要截短于250字)